litlas
ログインアカウント作成

Michael Charlton

1995–2026 年に発表

138
論文数
38,074
被引用数
92
h 指数
131
i10 指数

被引用数

Michael Charlton の年別被引用数1996 年: 被引用 2 件1997 年: 被引用 2 件1998 年: 被引用 2 件1999 年: 被引用 24 件2000 年: 被引用 28 件2001 年: 被引用 30 件2002 年: 被引用 56 件2003 年: 被引用 59 件2004 年: 被引用 85 件2005 年: 被引用 68 件2006 年: 被引用 89 件2007 年: 被引用 74 件2008 年: 被引用 61 件2009 年: 被引用 108 件2010 年: 被引用 99 件2011 年: 被引用 113 件2012 年: 被引用 140 件2013 年: 被引用 272 件2014 年: 被引用 273 件2015 年: 被引用 370 件2016 年: 被引用 456 件2017 年: 被引用 395 件2018 年: 被引用 493 件2019 年: 被引用 1,504 件2020 年: 被引用 1,767 件2021 年: 被引用 1,648 件2022 年: 被引用 1,314 件2023 年: 被引用 958 件2024 年: 被引用 1,710 件2025 年: 被引用 954 件2026 年: 被引用 46 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,108 件、この内訳の 24.2%中国: 引用元論文 2,093 件、この内訳の 12.3%イギリス: 引用元論文 991 件、この内訳の 5.8%イタリア: 引用元論文 969 件、この内訳の 5.7%ドイツ: 引用元論文 662 件、この内訳の 3.9%日本: 引用元論文 639 件、この内訳の 3.8%スペイン: 引用元論文 599 件、この内訳の 3.5%フランス: 引用元論文 552 件、この内訳の 3.2%韓国: 引用元論文 475 件、この内訳の 2.8%カナダ: 引用元論文 436 件、この内訳の 2.6%オーストラリア: 引用元論文 383 件、この内訳の 2.3%インド: 引用元論文 304 件、この内訳の 1.8%
0%24.2%その他 28.1%

機関

分野

  • Medicine85.1%
  • Biochemistry, Genetics and Molecular Biology9.9%
  • Immunology and Microbiology1.3%
  • Agricultural and Biological Sciences0.7%
  • Pharmacology, Toxicology and Pharmaceutics0.7%
  • Nursing0.5%
  • その他1.8%

トピック

  • Liver Disease Diagnosis and Treatment23.7%
  • Liver Disease and Transplantation7.7%
  • Diet, Metabolism, and Disease5.7%
  • Hepatitis C virus research3.8%
  • Liver Diseases and Immunity3%
  • Diabetes, Cardiovascular Risks, and Lipoproteins2.9%
  • その他53.2%

共著者

全論文

検索で開く
  1. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

    著者: Naga Chalasani, Zobair M. Younossi, Joel E. Lavine, Michael Charlton, Kenneth Cusi, Mary E. Rinella, Stephen A. Harrison, Elizabeth M. Brunt, Arun J. Sanyal - Hepatology 2017 被引用: 7,293

  2. A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

    著者: Stephen A. Harrison, Pierre Bédossa, Cynthia D. Guy, Jörn M. Schattenberg, Rohit Loomba, Rebecca Taub, Dominic Labriola, Sam E. Moussa, Guy Neff, Mary E. Rinella, Quentin M. Anstee, Manal F. Abdelmalek, Zobair M. Younossi, Seth J. Baum, Sven Francque, Michael Charlton, Philip N. Newsome, Nicolas Lanthier, Ingolf Schiefke, Alessandra Mangia, Juan M. Pericàs, Rashmee Patil, Arun J. Sanyal, Mazen Noureddin, Meena B. Bansal, Naim Alkhouri, Laurent Castéra, Madhavi Rudraraju, Vlad Ratziu - New England Journal of Medicine 2024 被引用: 1,701

  3. The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

    著者: Naga Chalasani, Zobair M. Younossi, Joel E. Lavine, Anna Mae Diehl, Elizabeth M. Brunt, Kenneth Cusi, Michael Charlton, Arun J. Sanyal - Hepatology 2012 被引用: 3,823

  4. Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance

    著者: Alan L. Hutchison, Federica Tavaglione, Stefano Romeo, Michael Charlton - Journal of Hepatology 2023 被引用: 227

  5. Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension

    著者: Naga Chalasani, Manal F. Abdelmalek, Guadalupe García–Tsao, Raj Vuppalanchi, Naim Alkhouri, Mary E. Rinella, Mazen Noureddin, Maxmillan Pyko, Mitchell L. Shiffman, Arun J. Sanyal, Adam Allgood, Harold Shlevin, R. G. Horton, Eliezer Zomer, William Irish, Zachary Goodman, Stephen A. Harrison, Peter G. Traber, Manal F. Abdelmalek, Luis A. Balart, Brian B. Borg, Naga Chalasani, Michael Charlton, Hari S. Conjeevaram, Michael Fuchs, Reem Ghalib, Pierre Gholam, Dina Halegoua‐De Marzio, Stephen A. Harrison, Christopher Jue, Nyingi Kemmer, Kris V. Kowdley, Michelle Lai, Eric Lawitz, Rohit Loomba, Mazen Noureddin, Angelo H. Paredes, Mary E. Rinella, Don C. Rockey, Miguel Rodriguez, Raymond A. Rubin, Michael Ryan, Arun J. Sanyal, Andrew Scanga, Thomas Sepe, Mitchell L. Shiffman, Mitchell L. Shiffman, Brent Tetri, Paul J. Thuluvath, Dawn M. Torres, John M. Vierling, Julia Wattacheril, Amanda Weiland, Donald L. Zogg - Gastroenterology 2019 被引用: 344

  6. The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

    著者: Naga Chalasani, Zobair M. Younossi, Joel E. Lavine, Anna Mae Diehl, Elizabeth M. Brunt, Kenneth Cusi, Michael Charlton, Arun J. Sanyal - Gastroenterology 2012 被引用: 1,774

  7. Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes

    著者: Petra Hirsova, Samar H. Ibrahim, Anuradha Krishnan, Vikas Verma, Steven F. Bronk, Nathan W. Werneburg, Michael Charlton, Vijay H. Shah, Harmeet Malhi, Gregory J. Gores - Gastroenterology 2016 被引用: 498

  8. Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis

    著者: Giovanni Musso, Roberto Gambino, James H. Tabibian, Mattias Ekstedt, Stergios Kechagias, Masahide Hamaguchi, Rolf Hultcrantz, Hannes Hagström, Seung Kew Yoon, Phunchai Charatcharoenwitthaya, Jacob George, Francisco Barrera, Svanhildur Hafliðadóttir, Einar S. Björnsson, Matthew J. Armstrong, Laurence Hopkins, Xin Gao, Sven Francque, An Verrijken, Yusuf Yılmaz, Keith D. Lindor, Michael Charlton, Robin Haring, Markus M. Lerch, Rainer Rettig, Henry Völzke, Seungho Ryu, Guolin Li, Linda L. Wong, Mariana Verdelho Machado, Helena Cortez‐Pinto, Kohichiroh Yasui, Maurizio Cassader - PLoS Medicine 2014 被引用: 723

  9. Liver Transplantation 2023: Status Report, Current and Future Challenges

    著者: Norah A. Terrault, Claire Francoz, Marina Berenguer, Michael Charlton, Julie K. Heimbach - Clinical Gastroenterology and Hepatology 2023 被引用: 284

  10. GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease

    著者: Rohit Loomba, Zeid Kayali, Mazen Noureddin, Peter Ruane, Eric Lawitz, Michael Bennett, Lulu Wang, Eliza Harting, Jacqueline M. Tarrant, B. Mccolgan, Chuhan Chung, Adrian S. Ray, G. Mani Subramanian, Robert P. Myers, Michael S. Middleton, Michelle Lai, Michael Charlton, Stephen A. Harrison - Gastroenterology 2018 被引用: 334

  11. The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial

    著者: Rohit Loomba, Eric Lawitz, Parvez Mantry, Saumya Jayakumar, Stephen H. Caldwell, Hays Arnold, Anna Mae Diehl, C. Stephen Djedjos, Ling Han, Robert P. Myers, G. Mani Subramanian, John G. McHutchison, Zachary Goodman, Nezam H. Afdhal, Michael Charlton, for the GS‐US‐384‐1497 Investigators - Hepatology 2017 被引用: 553

  12. Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis

    著者: Zobair M. Younossi, Rohit Loomba, Quentin M. Anstee, Mary E. Rinella, Elisabetta Bugianesi, Giulio Marchesini, Brent A. Neuschwander‐Tetri, Lawrence Serfaty, Francesco Negro, Stephen H. Caldwell, Vlad Ratziu, Kathleen E. Corey, Scott L. Friedman, Manal F. Abdelmalek, Stephen A. Harrison, Arun J. Sanyal, Joel E. Lavine, Philippe Mathurin, Michael Charlton, Zachary Goodman, Naga P. Chalasani, Kris V. Kowdley, Jacob George, Keith D. Lindor - Hepatology 2017 被引用: 427

  13. Complexity of ballooned hepatocyte feature recognition: Defining a training atlas for artificial intelligence-based imaging in NAFLD

    著者: Elizabeth M. Brunt, Andrew D. Clouston, Zachary Goodman, Cynthia D. Guy, David E. Kleiner, Carolin Lackner, Dina Tiniakos, Aileen Wee, Matthew M. Yeh, Wei Qiang Leow, Elaine Chng, Yayun Ren, George Boon‐Bee Goh, Elizabeth E. Powell, Mary E. Rinella, Arun J. Sanyal, Brent A. Neuschwander‐Tetri, Zobair M. Younossi, Michael Charlton, Vlad Ratziu, Stephen A. Harrison, Dean Tai, Quentin M. Anstee - Journal of Hepatology 2022 被引用: 153

  14. Expert Panel Recommendations: Practical Clinical Applications for Initiating and Monitoring Resmetirom in Patients With MASH/NASH and Moderate to Noncirrhotic Advanced Fibrosis

    著者: Mazen Noureddin, Michael Charlton, Stephen A. Harrison, Meena B. Bansal, Naim Alkhouri, Rohit Loomba, Arun J. Sanyal, Mary E. Rinella - Clinical Gastroenterology and Hepatology 2024 被引用: 136

  15. Hepatotoxicity From Immune Checkpoint Inhibitors: A Systematic Review and Management Recommendation

    著者: Thoetchai Peeraphatdit, Jennifer Wang, Matthew A. Odenwald, Shaomin Hu, John Hart, Michael Charlton - Hepatology 2020 被引用: 264

  16. Effects of Mediterranean Diet in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Randomized Controlled Trials

    著者: Takumi Kawaguchi, Michael Charlton, Atsushi Kawaguchi, Sakura Yamamura, Dan Nakano, Tsubasa Tsutsumi, Maryam Zafer, Takuji Torimura - Seminars in Liver Disease 2021 被引用: 115

  17. Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM study

    著者: Quentin M. Anstee, Kathryn Jean Lucas, Sven Francque, Manal F. Abdelmalek, Arun J. Sanyal, Vlad Ratziu, Adrián Gadano, Mary E. Rinella, Michael Charlton, Rohit Loomba, Edward Mena, Jörn M. Schattenberg, Mazen Noureddin, Donald J. Lazas, George Boon‐Bee Goh, Shiv K. Sarin, Yusuf Yılmaz, Miljen Martić, Rowan Stringer, Jossy Kochuparampil, Li Chen, Gerardo Rodriguez‐Araujo, Elaine Chng, Nikolai V. Naoumov, Clifford A. Brass, Marcos Pedrosa - Hepatology 2023 被引用: 65

  18. International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients

    著者: Michael Charlton, Josh Levitsky, Bashar Aqel, John O’Grady, Julie Hemibach, Mary E. Rinella, John J. Fung, Marwan Ghabril, Ray Thomason, Patrizia Burra, Ester C. Little, Marina Berenguer, Abraham Shaked, James F. Trotter, John P. Roberts, Manuel I. Rodríguez-Dávalos, Mohamed Rela, Elizabeth A. Pomfret, Caroline Heyrend, Juan F. Gallegos‐Orozco, Faouzi Saliba - Transplantation 2018 被引用: 302

  19. Rational combination therapy for NASH: Insights from clinical trials and error

    著者: Vlad Ratziu, Michael Charlton - Journal of Hepatology 2023 被引用: 64

  20. Efficacy and safety of an orally administered DGAT2 inhibitor alone or coadministered with a liver-targeted ACC inhibitor in adults with non-alcoholic steatohepatitis (NASH): rationale and design of the phase II, dose-ranging, dose-finding, randomised, placebo-controlled MIRNA (Metabolic Interventions to Resolve NASH with fibrosis) study

    著者: Neeta B. Amin, Amanda Darekar, Quentin M. Anstee, Vincent Wai‐Sun Wong, Frank Tacke, Manoli Vourvahis, Douglas S. Lee, Michael Charlton, Naim Alkhouri, Atsushi Nakajima, Carla Yunis - BMJ Open 2022 被引用: 51

  21. Bifidobacteria metabolize lactulose to optimize gut metabolites and prevent systemic infection in patients with liver disease

    著者: Matthew A. Odenwald, Huaiying Lin, Christopher Lehmann, Nicholas P. Dylla, Cody G. Cole, Jake D. Mostad, Téa E. Pappas, Ramanujam Ramaswamy, Angelica Moran, Alan L. Hutchison, M.R. Stutz, Mark Dela Cruz, Emerald Adler, Jaye Boissiere, Maryam Khalid, Jackelyn Cantoral, Fidel Haro, Rita A. Oliveira, Emily Waligurski, Thomas G. Cotter, S.H. Light, Kathleen G. Beavis, Anitha Sundararajan, Ashley M. Sidebottom, K. Gautham Reddy, Sonali Paul, Anjana Pillai, Helen S. Te, Mary E. Rinella, Michael Charlton, Eric G. Pamer, Andrew Aronsohn - Nature Microbiology 2023 被引用: 65

  22. Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition

    著者: Michael Charlton, Anuradha Krishnan, Kimberly Viker, Schuyler O. Sanderson, Sophie C. Cazanave, Andrea L. McConico, Howard Masuoko, Gregory J. Gores - American Journal of Physiology-Gastrointestinal and Liver Physiology 2011 被引用: 443

  23. Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

    著者: Zobair M. Younossi, Rohit Loomba, Mary E. Rinella, Elisabetta Bugianesi, Giulio Marchesini, Brent A. Neuschwander‐Tetri, Lawrence Serfaty, Francesco Negro, Stephen H. Caldwell, Vlad Ratziu, Kathleen E. Corey, Scott L. Friedman, Manal F. Abdelmalek, Stephen A. Harrison, Arun J. Sanyal, Joel E. Lavine, Philippe Mathurin, Michael Charlton, Naga Chalasani, Quentin M. Anstee, Kris V. Kowdley, Jacob George, Zachary Goodman, Keith D. Lindor - Hepatology 2017 被引用: 361

  24. Envisioning how to advance the MASH field

    著者: Alina M. Allen, Zobair M. Younossi, Anna Mae Diehl, Michael Charlton, Jeffrey V. Lazarus - Nature Reviews Gastroenterology & Hepatology 2024 被引用: 48